At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
2L Oral Bi-PegLyte Versus 2L Oral MoviPrep Regimen for Outpatient Colonic Preparation: A Randomized, Non-Inferiority Open Trial
In Brief
A Phase 4 clinical trial evaluating Polyethylene Glycol (PEG) and 15 mg Bisacodyl and Polyethylene Glycol (PEG) + ascorbic acid for Colonoscopy. Completed, enrolled 309 participants across 1 site.
Detailed Summary
This study is a randomized, controlled, single centre, endoscopist-blinded non-inferiority trial. The purpose of our study is to determine if using a 2-litre mixture in combination with vitamin C is better than using 2 litres of mixture with bisacodyl tablets. Two-litre PegLyte based preparations with an added laxative agent are commonly used for colonoscopies in outpatient settings. If the investigators discover that a 2-litre mixture with either the tablets or the ascorbic acid work better, future patients undergoing colonoscopy will be able to experience fewer side effects and be less troubled by the preparation while still allowing a good view of the colon.
Study Details
Timeline
Interventions
Subjects will be asked to take split dose of 2L PEG and 3 tablets of 5 mg Bisacodyl
Subjects will be asked to take split dose of 2L PEG and vitamin C